Russell/Engleman Rheumatology Research Center
The Russell/Engleman Rheumatology Research Center supports research, training, and patient care in the adult and pediatric rheumatology programs at UCSF.
Support from the Russell/Engleman Center promotes cutting edge research by internationally renowned scientists and clinicians to discover the causes and cures for potentially disabling and/or life-threatening rheumatologic diseases, including rheumatoid arthritis, osteoarthritis, juvenile arthritis, systemic lupus erythematosus, scleroderma, and many others. The Center also encourages and sustains the training of young physicians and scientists to become the next generation of leaders in the field of rheumatic diseases.
We hope that you will consider supporting our work through a tax-deductible contribution to the UCSF Division of Rheumatology.
About the Center
The Russell/Engleman Rheumatology Research Center at UCSF was established in 1979 by a one-time Congressional appropriation to posthumously honor Rosalind Russell, a famous stage and screen actress who had rheumatoid arthritis and who had been a tireless advocate for research to improve the lives of people with rheumatic diseases. Dr. Ephraim P. Engleman served as Director of the Center from its launch in 1979 until his death in 2015, at work, at age 104.
Learn more about Dr. Engleman and his work at the Center
During the pandemic, at a time when many people were at home and thirsty for current information, the Center introduced a series of webinars designed to provide accessible public education on topics of great interest to people with rheumatologic and autoimmune diseases, their families and friends. View some of the webinars below.
The Virus, the Vaccine, and You
This is the first in a series of free educational programs from the Center for people with rheumatologist diseases, their families and friends, and the generous donors who support our research, patients care, and education.
COVID-19 in Children – Multisystem Inflammatory Syndrome
This presentation provides an update on COVID-19 infection in children as of May 2022, with special emphasis on the Multisystem Inflammatory Syndrome in Children (MIS-C).
Leveraging Nutrition & Lifestyle to Improve Outcomes in Rheumatologic Diseases
Get in Touch
Reach out for more information or ways to get involved.
Arthritis Progress Reports
Read about the most recent work and news from the Russell/ Engleman Rheumatology Research Center.